Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,346.80
(
0.17%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
107.64
(
3.09%
)
Bitcoin
77,051.35
(
0.93%
)
News Focus
News Focus
Post# of 257458
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: maverick_1 post# 194449

Tuesday, 08/18/2015 5:42:19 PM

Tuesday, August 18, 2015 5:42:19 PM

Post# of 257458
One issue for me is that the OMER drug is earlier in the complement pathway than is Soliris - see my comment here:

http://www.siliconinvestor.com/readmsg.aspx?msgid=29434460

An aHUS expert might well have an answer to this theoretical concern of mine based on the data released today.

Peter

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today